What Device Manufacturers Can Learn From FDA’s Inspection Data

The GMP Letter
Medical device quality managers that don’t want to wind up a statistic in a future FDA report on quality deviations should dig deeply into the agency’s recently released report on inspections, Form 483s and warning letters, says Michael Gaba, a partner in the law firm Polsinelli.

To View This Article:


Subscribe To The GMP Letter